Switzerland startup funding in 2014
European tech funding raised by Switzerland startups during 2014.
In 2014, 40 startups in Switzerland closed 44 funding rounds and raised €288M in equity funding (excluding debt and grants). Debt rounds added €7.7M. Healthtech was the most active sector, and Swisscom Ventures was the most active investor. Data as of 6 Nov 2026.
Equity funding
€288M
excl. debt & grants · +€7.7M debt
Funding rounds
44
Companies
40
Top sector
Healthtech
Switzerland: last three years
change vs the year before| Year | Equity | Change | Rounds | Change | Debt |
|---|---|---|---|---|---|
| 2012 | €130M | -26.5% | 25 | -3.8% | — |
| 2013 | €220M | +68.8% | 42 | +68.0% | €3.3M |
| 2014 | €288M | +31.4% | 44 | +4.8% | €7.7M |
Rank in Europe
#7
3.1% of European funding
Debt financing
€7.7M
2.6% of total
Top-10 round share
85.1%
of disclosed capital
Funding by month
€ raised vs rounds, by monthSwitzerland — funding by month, 2014 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €19M | 2 |
| Feb | €50M | 5 |
| Mar | €4.2M | 3 |
| Apr | €53M | 8 |
| May | €30M | 3 |
| Jun | €9.1M | 6 |
| Jul | €14M | 3 |
| Aug | €2.9M | 5 |
| Sep | €65M | 1 |
| Oct | €0 | 1 |
| Nov | €399k | 2 |
| Dec | €51M | 5 |
Top sectors
by € raisedSwitzerland — top sectors by capital, 2014 — interactive chart.
Data table
| Switzerland — top sectors by capital, 2014 | |
|---|---|
| Healthtech | €233M |
| Software | €39M |
| Cybersecurity | €24M |
| Telecom | €22M |
| Marketing | €4.6M |
| Deeptech | €4.0M |
| Wellness & Beauty | €3.1M |
| Hardware | €1.5M |
Stage mix
by € raisedSwitzerland — stage mix, 2014 — interactive chart.
Data table
| Switzerland — stage mix, 2014 | |
|---|---|
| Series D+ | €143M |
| Series B | €58M |
| Growth/Late | €27M |
| Series A | €26M |
| Series C | €17M |
| Debt | €7.7M |
| Early VC | €6.5M |
| Seed | €6.1M |
| Other | €5.4M |
| Grant | €1.7M |
Largest equity rounds
by disclosed amount, 2014| Company | Stage | Date | Amount |
|---|---|---|---|
| Biocartis | Series D+ | Sep 2014 | €65M |
| NovImmune | Series D+ | Feb 2014 | €49M |
| Xeltis | Series B | Dec 2014 | €27M |
| CRISPR Therapeutics | Series A | Apr 2014 | €23M |
| Silent Circle | Growth/Late | May 2014 | €22M |
| AC Immune | Series D+ | Jan 2014 | €18M |
| Sequana Medical | Series C | Apr 2014 | €17M |
| Anergis | Series B | Dec 2014 | €12M |
| Nexthink | Series D+ | Dec 2014 | €12M |
| Sophia Genetics | Series B | Jul 2014 | €10M |
Largest debt rounds
debt financing, 2014; not in the equity totalTop investors
most active in 2014, by deal count- Swisscom Ventures5 deals
- VI Partners3 deals
- Life Sciences Partners2 deals
- EntrePREneurs Fund1 deals
- Euroventures Capital Advisory1 deals
- Henry Schein1 deals
- Invoke Capital Partners1 deals
- Mannai Corporation1 deals
- Marcus Bonalumi1 deals
- Auriga Partners1 deals
Source: Tech.eu Funding Explorer · data as of 6 Nov 2026 · licence CC BY 4.0 · Methodology